Birnbaumer / O'Malley Receptors and Hormone Action

Volume III
1. Auflage 2013
ISBN: 978-1-4832-6272-7
Verlag: Elsevier Science & Techn.
Format: EPUB
Kopierschutz: 6 - ePub Watermark

E-Book, Englisch, 648 Seiten

Receptors and Hormone Action, Volume III, is part of a multivolume series that summarizes advances in the field of hormone action. The articles contained in these books are oriented toward a description of basic methodologies and model systems used in the exploration of the molecular bases of hormone action, and are aimed at a broad spectrum of readers including those who have not yet worked in the field as well as those who have considerable expertise in one or another aspect of hormone action. This book opens with a chapter on the physiological properties of the thyroid hormone receptors in the intact animal. This is followed by separate chapters on á-adrenergic receptors; the study of hormone-receptor interaction by measuring the biological responses induced by the actions of gonadotropins on Leydig cells; chemical and immunochemical properties of hCG and PMSG treated with glycosidases; and binding of follitropin (FSH) to rat testes. Subsequent chapters deal with the control of changes of gonadotropin responsiveness of the granulosa cell during follicular maturation; regulation of prolactin receptors by steroid hormones; and the role of membrane protein phosphorylation in the effects of neurotransmitters.

Autoren/Hrsg.

Birnbaumer, Lutz

O'Malley, Bert

Leseproben

List of Contributors

Numbers in parentheses indicate the pages on which the authors’ contributions begin.

HUSSEIN ABOU-ISSA,     (341), Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia 30322

G.D. AURBACH,     (101), Metabolic Diseases Branch, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014

OM P. BAHL,     (221, 261), Department of Biological Sciences, State University of New York at Buffalo, Buffalo, New York 14260

JOHN D. BAXTER,     (75), Endocrine Research Division, Departments of Medicine, Biochemistry, and Biophysics, University of California, San Francisco, California 94143

M. BEAULIEU,     (493), Medical Research Council Group in Molecular Endocrinology, Le Centre Hospitalier de l’Université Laval, Quebec, G1V 4G2, Canada

L. BIRNBAUMER,     (133, 393), Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030

JOEL BOCKAERT,     (393), Laboratoire de Physiologie Cellulaire, Collège de France, 75231 Paris, France

H.G. BOHNET*,     (457), Department of Physiology, University of Manitoba, Winnipeg, Manitoba R3E OW3, Canada

E.M. BROWN,     (101), Metabolic Diseases Branch, and Digestive Diseases Branch, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014

K.J. CATT,     (291), Endocrinology and Reproduction Research Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20014

CORNELIA P. CHANNING,     (435), Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland 21201

JAMES H. CLARK,     (515), Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030

JOHN R. DEDMAN,     (363), Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030

A. DE LÉAN,     (493), Medical Research Council Group in Molecular Endocrinology, Le Centre Hospitalier de l’Université Laval, Quebec G1V 4G2, Canada

W.H. DILLMANN,     (1), Section of Endocrinology, Department of Medicine and Physiology, University of Minnesota, Minneapolis, Minnesota 55455

J. DROUIN,     (493), Medical Research Council Group in Molecular Endocrinology, Le Centre Hospitalier de l’Université Laval, Quebec, G1V 4G2, Canada

M.L. DUFAU,     (291), Endocrinology and Reproduction Research Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20014

JOHN L. FAKUNDING*,     (363), Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030

L. FERLAND,     (493), Medical Research Council Group in Molecular Endocrinology, Le Centre Hospitalier de l’Université Laval, Quebec, G1V 4G2, Canada

H.G. FRIESEN,     (457), Department of Physiology, University of Manitoba, Winnipeg, Manitoba R3E OW3, Canada

J.D. GARDNER,     (101), Digestive Diseases Branch, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 22214

BLYNN L. GARLAND,     (535), Biological Psychiatry Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20014

HOWARD M. GOODMAN,     (75), Department of Biochemistry and Biophysics, University of California School of Medicine, San Francisco, California 94143

MARY HUNZICKER-DUNN,     (393), Department of Biochemistry, The Medical and Dental Schools, Northwestern University, Chicago, Illinois 60611

A.J. KAUMANN,     (133), Department of Clinical Physiology, Institute of Physiology, University of Dusseldorf, 4000 Dusseldorf, Federal Republic of Germany

JOHN W. KEBABIAN*,     (195), Pharmacology-Toxicology Program, National Institute of General Medical Sciences, National Institutes of Health, Bethesda, Maryland 20014

F. LABRIE,     (493), Medical Research Council Group in Molecular Endocrinology, Le Centre Hospitalier de l’Université Laval, Quebec G1V 4G2, Canada

L. LAGRACE,     (493), Medical Research Council Group in Molecular Endocrinology, Le Centre Hospitalier de l’Université, Laval, Quebec, G1V 4G2, Canada

KEITH R. LATHAM†,     (75), Endocrine Research Division, Departments of Medicine, Biochemistry, and Biophysics, University of California, San Francisco, California 94143

FLORENCE LEDWITZ-RIGBY,     (435), Department of Biological Sciences, Northern Illinois University, DeKalb, Illinois 60115

EDDINGTON Y. LEE,     (221), Department of Physiology, Harvard Medical School, Boston, Massachusetts 02115

ROBERT J. LEFKOWITZ,     (179), Department of Medicine, Division of Cardiovascular Disease, Duke University Medical Center, Durham, North Carolina 27710

A.M. LINDSEY‡,     (435), Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland 21201

KATHRYN M. MacLEOD,     (75), Endocrine Research Division, Department of Medicine, University of California, San Francisco, California 94143

JOSEPH A. MARTIAL,     (75), Endocrine Research Division, Departments of Medicine, Biochemistry, and Biophysics, University of California, San Francisco, California 94143

ANTHONY R. MEANS,     (363), Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030

O. MORIN,     (493), Medical Research Council Group in Molecular Endocrinology, Le Centre Hospitalier de l’Université Laval, Quebec G1V 4G2, Canada

WILLIAM R. MOYLE,     (221, 261), Department of Biological Chemistry, Harvard Medical School, Boston, Massachusetts 02115

ROBERT F. O’DEA*,     (195), Section of Pharmacology, Laboratory of Clinical Science, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20014

J.H. OPPENHEIMER,     (1), Section of Endocrinology, Department of Medicine and Physiology, University of Minnesota, Minneapolis, Minnesota 55455

STATHIS S. PAPAVASILIOU,     (75), Endocrine Research Division, Department of...